Anita Lalloo is an Associate Director in Global Regulatory Affairs - CMC at Merck. She is currently responsible for developing CMC regulatory strategies aligned with market regulations, liaising with global Regulatory Agencies to discuss novel technologies and submission strategies and translating technical risks into regulatory risks together with developing robust mitigations. Anita is responsible for preparing Merck’s first continuous manufacturing market application. She has more than 10 years of experience in drug development spanning from early formulation development through to commercial manufacturing site experience. Anita received her Ph.D. in Pharmaceutical Sciences from Rutgers University.